Type 2 diabetes in the United States is on the rise. Millions of individuals are asymptomatic yet have undiagnosed diabetes. With daunting numbers of individuals who are obese, inactive, and have other risk factors that contribute to the development of diabetes, it is imperative for practitioners to screen individuals at point of care (POC) in an attempt to diagnose type 2 diabetes as early as possible to assure early management of glycemic control to prevent future complications. Current standards of care recommend using the plasma AIc as one possible test for diagnosing and screening for diabetes in patients with known risk factors, and those over 45 years of age. There is good evidence that the Alc is a reliable test for diagnosing diabetes, and the POC test is as accurate as the laboratory Al c. Studies indicate that individuals may have elevated blood sugars for years before an actual diagnosis of diabetes is known. Research also suggests that this hyperglycemic period can be as long as 7-12 years before symptoms occur, though the exact number of years is unknown. Once symptoms of diabetes have occurred, there are indications that retinopathy, nephropathy, and neuropathy are already underway. Further, studies have shown that lifestyle interventions of weight loss, exercise, diet, and oral anti-diabetic medications can delay or prevent a diagnosis of diabetes. Using the Chronic Care Model as a guiding framework, this paper reviews available literature to determine the advisability of using POC Alc to screen tor type 2 diabetes .
Metrics
3 File views/ downloads
27 Record Views
Details
Title
The Advisibility of Using A1c as a Screening Method for Early Detection of Type 2 Diabetes Mellitus
Creators
Jody B. Gray
Contributors
Cynthia Corbett (Advisor)
Awarding Institution
Washington State University
Academic Unit
Research Projects, College of Nursing
Theses and Dissertations
Master of Nursing (MN), Washington State University
Publisher
Washington State University; Spokane, Washington
Identifiers
99900590722601842
Copyright
http://creativecommons.org/licenses/by-nc-sa/3.0/us; Creative Commons Attribution-NonCommercial-ShareAlike 3.0 United States (CC BY-NC-SA 3.0 US)